CollPlant Biotechnologies financial statements
콜플란트 바이오테크놀로지스NASDAQ:CLGN · Nasdaq · Healthcare · sector #17$3.39-0.59%
2026-10-06 closeCollPlant Biotechnologies's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$17M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy